Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different? The expected results were quite the same with no additional side effects and a decrease in mania score. Decision #3 Why did you select this decision?

Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different? The expected results were quite the same with no additional side effects and a decrease in mania score. Decision #3 Why did you select this decision?

Support your response with evidence and references to the Learning Resources. After getting a good result with a 50% decrease in the Young Mania Rating score from 22 to 11 and no additional side effects, I will continue the same dose and reassess in four weeks. I chose to decide this because increasing the dosage could lead to arise in side effects. One study suggests that a shorter duration of treatment with Ziprasidone is needed to reduce the risk of long-term adverse effects (Mazza, Marano, Giuseppin, & Janiri, 2020

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources. Within four weeks, the patient will show good progress because there were no side effects that the patient addressed after taking Geodon for four weeks. She will have a decrease in maniac symptoms. Oral Ziprasidone is FDA approved for the treatment of manic episodes with bipolar disorder (Mazza, Marano, Giuseppin, & Janiri, 2020). Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different? As expected at the second decision, the patient showed significant progress and no additional side effects of dry mouth or constipation. And to achieve better results continuing the same dose and reassess after four weeks helped the symptoms. Also, include how ethical considerations might impact your treatment plan and communication with clients. In treating patients with bipolar disorder, ethical considerations that might impact the treatment plan and communication are autonomy, beneficence, and nonmaleficence. Despite the way that patients need treatment to live a healthy and normal life, it is important to balance the dangers of selecting drugs that could correspond with benefits. Then again, a mental healthcare provider must give the patient the absolute best accessible choices for treatment to amplify the advantages of medication. The judgment is always challenged in a patient who is going through maniac episodes, sometimes they are not ready to provide consent and make a decision about their treatment and this is where the conflict arises with the autonomy of the patient to make decisions that could cause no threat with therapeutic interventio